- Opinion
- [Reporter’s View] MFDS’ Regulatory Innovation 3.0
- by Lee, Hye-Kyung May 14, 2024 05:48am
- The Ministry of Food and Drug Safety (MFDS)’s announcement of the regulatory innovation tasks is now an annual event. The Regulatory Innovation 1.0, announced just two months after Oh Yu-kyoung’s appointment as the minister, focused on regulations that need system improvements. Since 1.0 was criticized for not considering citizens’ opini
- Opinion
- [Reporter’s View] The dark side of the coveted MNC jobs
- by Eo, Yun-Ho May 10, 2024 05:47am
- Multinational pharmaceutical companies have become the wannabe companies for job seekers. With high salaries that are comparable to those of large companies and the flexible working arrangements that allow remote work, generous vacation days, generous in-house benefits, and a horizontal corporate culture, it seems anyone would jump at the ch
- Opinion
- [Reporter’s View] Patients are left to suffer amid dispute
- by Lee, Jeong-Hwan Apr 29, 2024 05:50am
- It has been 3 months since the doctors and the government failed to see eye to eye on the government’s plan to expand medical school admissions by 2,000 students. The prolonged dispute has intensified animosity towards each other. The doctors have criticized the Minister and Vice Minister of Health and Welfare, Kyoo-hong Cho and Minsoo P
- Opinion
- [Reporter’s View] Introducing shingles vaccines into NIP
- by Eo, Yun-Ho Apr 26, 2024 05:47am
- &160;It started as a presidential election pledge during the candidacy of the current president, and then became a pledge by most parties in the recent general election. It has also been pointed out at the National Assembly audit. The agenda in issue is the introduction of the shingles vaccine into the National Immunization Program (NIP).
- Opinion
- [Reporter’s View] Decreased vaccine funding during endemic
- by Son, Hyung-Min Apr 24, 2024 05:44am
- K-bio and Vaccine Fund No.3 is soon to be launched. Considering the recent contraction of the investment market, the entire amount of KRW 40 billion of investment money from the government and the government-run bank has been invested, regardless of the formation size. Once the initial formation of KRW 70 billion is raised, early investmen
- Opinion
- [Reporter’s View] Additions to the post-management system
- by Eo, Yun-Ho Apr 12, 2024 05:41am
- “The introduction of the post-management system aims to secure additional evidence related to medicines of uncertain safety and efficacy. The system is intended to improve healthcare by reverifying those medicines with medical knowledge.” Although the intention seems reasonable, some are voicing concerns. The concern is that reinforci
- Opinion
- [Reporter’s View] Delays in reimbursement listing
- by Lee, Tak-Sun Apr 9, 2024 05:50am
- Last January, the Health Insurance Review and Assessment Service (HIRA) posted a document explaining the delay in listing and related press reports. The message was that the HIRA strives to implement faster listing, but pharmaceutical companies must cooperate. “Pharmaceutical companies must submit relevant documents for drugs subject
- Opinion
- [Reporter’s View] Results needed for ‘Ilaris’ on hold
- by Eo, Yun-Ho Apr 1, 2024 05:29am
- It made its third attempt, but Ilaris faced another challenge. ‘Ilaris,’ a drug for about ten patients in South Korea, has not cleared the Drug Reimbursement Evaluation Committee (DREC) of the Health Insurance Review and Assessment Service (HIRA) and is on hold. Novartis Korea’s Ilaris (canakinumab), a drug used to treat periodic fever
- Opinion
- [Reporter’s View] Let Enhertu’s case guide new listings
- by Eo, Yun-Ho Mar 19, 2024 05:44am
- The reimbursement listing of the advanced ADC anti-cancer drug Enhertu is imminent. The company completed drug pricing negotiations with the National Health Insurance Service at a ‘superfast’ speed when considering the slow progress it had made during previous procedures. At this pace, Enhertu is likely to be reimbursed in April this year.
- Opinion
- [Reporter’s View] 'Tylenol,' no longer produced,
- by Lee, Hye-Kyung Mar 18, 2024 05:49am
- Twelve years have passed since the government desginated over-the-counter emergency medicines. On November 15, 2012, the government implemented 13 over-the-counter (OTC) emergency medicines, including antipyretic analgesics, gastrointestinal medicine, and patches. When designating 13 OTC emergency medicines, the government based its eval
